COMPASS Pathways Price to Book Ratio 2019-2025 | CMPS
Historical price to book ratio values for COMPASS Pathways (CMPS) over the last 10 years. The current price to book ratio for COMPASS Pathways as of July 09, 2025 is 1.68.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
COMPASS Pathways Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-07-10 | 3.72 | 1.77 | |
2025-03-31 | 2.86 | $2.11 | 1.36 |
2024-12-31 | 3.78 | $2.26 | 1.68 |
2024-09-30 | 6.30 | $2.82 | 2.23 |
2024-06-30 | 6.04 | $3.31 | 1.83 |
2024-03-31 | 8.32 | $3.79 | 2.19 |
2023-12-31 | 8.75 | $3.64 | 2.40 |
2023-09-30 | 7.40 | $4.09 | 1.81 |
2023-06-30 | 8.28 | $3.64 | 2.28 |
2023-03-31 | 9.93 | $3.78 | 2.63 |
2022-12-31 | 8.03 | $4.25 | 1.89 |
2022-09-30 | 10.73 | $4.57 | 2.35 |
2022-06-30 | 10.82 | $5.28 | 2.05 |
2022-03-31 | 12.89 | $6.11 | 2.11 |
2021-12-31 | 22.10 | $6.77 | 3.27 |
2021-09-30 | 29.87 | $7.32 | 4.08 |
2021-06-30 | 38.15 | $7.85 | 4.86 |
2021-03-31 | 36.82 | $5.13 | 7.18 |
2020-12-31 | 47.64 | $5.47 | 8.71 |
2020-09-30 | 34.90 | $5.65 | 6.17 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.330B | $0.000B |
COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $143.821B | 26.97 |
CVS Health (CVS) | United States | $84.326B | 10.48 |
Elevance Health (ELV) | United States | $78.255B | 10.10 |
Cencora (COR) | United States | $58.178B | 20.24 |
DiDi Global (DIDIY) | China | $23.485B | 24.95 |
Natera (NTRA) | United States | $22.086B | 0.00 |
Labcorp Holdings (LH) | United States | $21.684B | 17.59 |
BioMerieux (BMXMF) | France | $16.861B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $13.804B | 0.00 |
Solventum (SOLV) | United States | $12.836B | 13.59 |
CochLear (CHEOY) | Australia | $12.824B | 0.00 |
ICON (ICLR) | Ireland | $12.156B | 11.30 |
Revvity (RVTY) | United States | $11.802B | 20.31 |
Viatris (VTRS) | United States | $10.833B | 3.72 |
Avantor (AVTR) | United States | $9.247B | 13.44 |
Medpace Holdings (MEDP) | United States | $9.225B | 24.50 |
HealthEquity (HQY) | United States | $8.646B | 37.87 |
Sonic Healthcare (SKHHY) | Australia | $8.518B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.808B | 15.30 |
Caris Life Sciences,�Inc (CAI) | United States | $6.930B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.971B | 29.27 |
BrightSpring Health Services (BTSG) | United States | $3.760B | 34.50 |
Sotera Health (SHC) | United States | $3.296B | 18.73 |
Surgery Partners (SGRY) | United States | $2.870B | 37.32 |
Alignment Healthcare (ALHC) | United States | $2.750B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.622B | 100.97 |
Concentras Parent (CON) | United States | $2.619B | 15.13 |
Organon (OGN) | United States | $2.576B | 2.74 |
Progyny (PGNY) | United States | $2.038B | 44.87 |
Ardent Health (ARDT) | United States | $1.981B | 8.45 |
PACS (PACS) | United States | $1.957B | 0.00 |
Premier (PINC) | United States | $1.778B | 13.49 |
GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
Teladoc Health (TDOC) | United States | $1.553B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.303B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
CareDx (CDNA) | United States | $1.129B | 17.64 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
Agilon Health (AGL) | United States | $0.948B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.846B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.833B | 7.80 |
Nutex Health (NUTX) | United States | $0.643B | 9.73 |
Embecta (EMBC) | United States | $0.619B | 4.17 |
InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
SBC Medicals (SBC) | United States | $0.546B | 0.00 |
LifeMD (LFMD) | United States | $0.535B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.471B | 10.62 |
So-Young (SY) | China | $0.440B | 0.00 |
Omada Health (OMDA) | $0.434B | 0.00 | |
Enhabit (EHAB) | United States | $0.368B | 30.29 |
Performant Healthcare (PHLT) | United States | $0.335B | 0.00 |
Beauty Health (SKIN) | United States | $0.263B | 0.00 |
Oncology Institute (TOI) | United States | $0.216B | 0.00 |
DocGo (DCGO) | United States | $0.159B | 26.00 |
Pheton Holdings (PTHL) | China | $0.132B | 0.00 |
Sera Prognostics (SERA) | United States | $0.100B | 0.00 |
KindlyMD (NAKA) | United States | $0.074B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.067B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
ModivCare (MODV) | United States | $0.060B | 0.00 |
Biodesix (BDSX) | United States | $0.046B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
OSR Holdings (OSRH) | United States | $0.024B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |